| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/24/2012 | US8101718 Methods of administering porcine B-domainless fVIII |
| 01/24/2012 | US8101717 Use of tropoelastin for repair or restoration of tissue |
| 01/24/2012 | US8101716 Human interferon-beta mutein |
| 01/24/2012 | US8101715 Ryanodine receptor polypeptides |
| 01/24/2012 | US8101713 Prostate cancer diagnosis and treatment |
| 01/24/2012 | US8101712 Extracting impurities from broth having echinocandin compound with non polar water-immiscible organic solvent to obtain first two-phase system comprising aqueous phase and organic phase, removing organic phase, extracting echinocandin from aqueous phase with water-immiscible solvent |
| 01/24/2012 | US8101676 Osteogenic paste compositions and uses thereof |
| 01/24/2012 | US8101663 Polymorphs of suberoylanilide hydroxamic acid |
| 01/24/2012 | US8101652 For therapy of neoplastic diseases |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101584 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 01/24/2012 | US8101580 Therapeutic agent for irritable bowel syndrome |
| 01/24/2012 | US8101579 Methods and compositions for the treatment of gastrointestinal disorders |
| 01/24/2012 | US8101578 Amyloid [β] Beta fibrillogenesis-inhibiting peptide |
| 01/24/2012 | US8101577 Oxidative DNA damage protection |
| 01/24/2012 | US8101576 Compounds and their effects on feeding behaviour |
| 01/24/2012 | US8101575 Glycopeptide phosphonate derivatives |
| 01/24/2012 | US8101574 Oligopeptides and compositions containing the oligopeptides |
| 01/24/2012 | US8101573 α-conotoxin MII analogs |
| 01/24/2012 | US8101572 Methods for promoting wound healing and/or reducing scar formation |
| 01/24/2012 | US8101571 Treatment methods using NGF variants |
| 01/24/2012 | US8101570 Single branch heparin-binding growth factor analogs |
| 01/24/2012 | US8101569 Energy status of an individual by enhanced production of an endogenous fuel source |
| 01/24/2012 | US8101567 Heteroaryl-containing tripeptide HCV serine protease inhibitors |
| 01/24/2012 | US8101566 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 01/24/2012 | US8101565 Sustained release of Apo A-I mimetic peptides and methods of treatment |
| 01/24/2012 | US8101564 Methods for regulating osteoclast differentiation and bone resorption using LRRc17 |
| 01/24/2012 | US8101412 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 01/24/2012 | US8101393 Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
| 01/24/2012 | US8101381 Human cytokine receptor |
| 01/24/2012 | US8101363 Obtaining a level of a marker of systemic inflammation in individual, comparing level of marker to a predetermined value specific for diagnosis of diabetes or diabetic complications, and characterizing the individual's risk profile |
| 01/24/2012 | US8101349 For use in diagnostics and therapeutics |
| 01/24/2012 | US8101348 RNA-interference by single-stranded RNA molecules |
| 01/24/2012 | US8101347 Method and compositions for immunization with the Pseudomonas V antigen |
| 01/24/2012 | US8101343 protecting against parasites and predators; transgenic organisims |
| 01/24/2012 | US8101198 Osteogenic enhancer composition |
| 01/24/2012 | US8101196 Medical gel; crosslinking |
| 01/24/2012 | US8101194 Immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/24/2012 | US8101188 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/24/2012 | US8101187 Secreted Streptococcus pneumoniae proteins |
| 01/24/2012 | US8101186 Peptides that block the binding of IgG to FcRn |
| 01/24/2012 | US8101176 Compositions and methods related to TIM-3, a TH1-specific cell surface molecule |
| 01/24/2012 | US8101174 Tumor necrosis factor cleaving agent for use in diagnosis, prevention and treatment of inflammatory disorders |
| 01/24/2012 | US8101166 Methods for the treatment of IL-1β related diseases |
| 01/24/2012 | US8101165 Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors |
| 01/24/2012 | US8101162 Hair growth composition |
| 01/24/2012 | US8101160 Formulations for use in inhaler devices |
| 01/24/2012 | US8100169 Spray nozzle apparatus and method of use |
| 01/24/2012 | CA2518169C A recombinant constructed by a virus vector and a human tumor suppressor gene and its use |
| 01/24/2012 | CA2494761C Oral pharmaceutical compositions comprising cyclosporin |
| 01/24/2012 | CA2494340C Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 01/24/2012 | CA2487168C Novel nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same |
| 01/24/2012 | CA2480567C Mixed-cell gene therapy |
| 01/24/2012 | CA2478825C Composition having gelling properties for the prolonged delivery of bioactive substances |
| 01/24/2012 | CA2470230C Pharmaceutical formulation comprising cyclosporin and use thereof |
| 01/24/2012 | CA2462857C Angiotensin peptide-carrier conjugates and uses thereof |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2439428C Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/24/2012 | CA2410828C Duplexed parvovirus vectors |
| 01/24/2012 | CA2406168C Polyamide nucleic acid derivatives, agents and methods for producing same |
| 01/24/2012 | CA2386920C Oncolytic virus |
| 01/24/2012 | CA2383174C Method of treating cardio pulmonary diseases with no group compounds |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2351877C Methods and compositions for pain management |
| 01/24/2012 | CA2344317C Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 01/24/2012 | CA2332370C Methods and means for preventing or treating inflammation or pruritis |
| 01/24/2012 | CA2324901C Pharmaceutical compositions for prolonged peptide release and preparation method |
| 01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
| 01/24/2012 | CA2274987C Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 01/24/2012 | CA2269204C Anti-erbb2 antibodies |
| 01/24/2012 | CA2260754C Novel vegf-like factor |
| 01/24/2012 | CA2221730C Use of angiotensin ii type 2 receptor agonists in tissue repair |
| 01/22/2012 | CA2746922A1 Compositions and methods for increasing lean muscle mass after exercise |
| 01/20/2012 | DE20321887U1 Arzneimittel umfassend niedrige Dosierungen von Desmopressin A pharmaceutical composition comprising low doses of desmopressin |
| 01/19/2012 | WO2012009715A2 Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
| 01/19/2012 | WO2012009705A1 Ang-2 binding complexes and uses thereof |
| 01/19/2012 | WO2012009631A1 Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods |
| 01/19/2012 | WO2012009503A1 Palatable pharmaceutical composition comprising vx-950 |
| 01/19/2012 | WO2012009471A1 Anti-angiogenic agent and method of using such agent |
| 01/19/2012 | WO2012009447A2 THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF |
| 01/19/2012 | WO2012009336A1 Romidepsin solid forms and uses thereof |
| 01/19/2012 | WO2012009289A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| 01/19/2012 | WO2012009075A1 Materials and method for suppressing inflamatory and neuropathic pain |
| 01/19/2012 | WO2012008967A1 Self-assembling peptides incorporating modifications and methods of use thereof |
| 01/19/2012 | WO2012008869A1 Aprotinin-based aerosol preparation for the treatment of viral respiratory infections |
| 01/19/2012 | WO2012008834A1 Microparticles comprising a small heat-shock protein |
| 01/19/2012 | WO2012008779A2 A liquid formulation of long-acting human growth hormone conjugate |
| 01/19/2012 | WO2012008302A1 Method for preparing novel hipsc by means of mirna introduction |
| 01/19/2012 | WO2012008301A1 Method for producing novel hipsc by means of sirna introduction |
| 01/19/2012 | WO2012007978A2 Fermented soya based mixture comprising isoflavones- aglicones, equol and lunasil, process for the preparation and uses thereof in food, medical and cosmetic fields. |
| 01/19/2012 | WO2012007777A1 Novel proteins, process for preparation thereof, and use thereof |
| 01/19/2012 | WO2012007711A1 Formulation comprising a type b lantibiotic |
| 01/19/2012 | WO2012007658A2 Use of the pat nonapeptide in treating and preventing neurodegenerative diseases |
| 01/19/2012 | WO2012007625A1 Compounds that can be used as systems for delivery across the blood-brain barrier, and delivery system/load constructs |
| 01/19/2012 | WO2012007538A1 Ferrimannitol-ovalbumin tablet composition |
| 01/19/2012 | WO2012007324A2 Stabilized factor viii variants |
| 01/19/2012 | WO2012007137A1 Peptide for use in the treatment of breast cancer and/or bone metastases |
| 01/19/2012 | WO2012006962A1 Truncated human papillomavirus type 58 l1 protein |
| 01/19/2012 | WO2012006956A1 Insulin-lipid complex, preparation method therefor, and preparation thereof |
| 01/19/2012 | WO2012006667A1 Method of treatment of hiv or aids |